Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity

We conducted a serological study to define correlates of immunity against SARS-CoV-2. Compared to those with mild coronavirus disease 2019 (COVID-19) cases, individuals with severe disease exhibited elevated virus-neutralizing titers and antibodies against the nucleocapsid (N) and the receptor bindi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ripperger, Tyler J., Uhrlaub, Jennifer L., Watanabe, Makiko, Wong, Rachel, Castaneda, Yvonne, Pizzato, Hannah A., Thompson, Mallory R., Bradshaw, Christine, Weinkauf, Craig C., Bime, Christian, Erickson, Heidi L., Knox, Kenneth, Bixby, Billie, Parthasarathy, Sairam, Chaudhary, Sachin, Natt, Bhupinder, Cristan, Elaine, El Aini, Tammer, Rischard, Franz, Campion, Janet, Chopra, Madhav, Insel, Michael, Sam, Afshin, Knepler, James L., Capaldi, Andrew P., Spier, Catherine M., Dake, Michael D., Edwards, Taylor, Kaplan, Matthew E., Scott, Serena Jain, Hypes, Cameron, Mosier, Jarrod, Harris, David T., LaFleur, Bonnie J., Sprissler, Ryan, Nikolich-Žugich, Janko, Bhattacharya, Deepta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554472/
https://www.ncbi.nlm.nih.gov/pubmed/33129373
http://dx.doi.org/10.1016/j.immuni.2020.10.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554472/
https://www.ncbi.nlm.nih.gov/pubmed/33129373
http://dx.doi.org/10.1016/j.immuni.2020.10.004

Ejemplares similares